Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
07/2006
07/20/2006WO2006075139A2 Novel process for the preparation of substituted indoles
07/20/2006WO2006054162A8 Azabicyclic muscarinic receptor antagonists
07/20/2006WO2006015060A3 Isoindoline compounds and methods of their use
07/20/2006WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
07/20/2006WO2004091382A3 Monitoring circadian activity
07/20/2006US20060161006 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
07/20/2006US20060161002 Tetrahydrocarbazole derivatives and their pharmaceutical use
07/20/2006US20060160894 Benzamides as ppar modulators
07/20/2006US20060160884 N-{[4-(but-2-ynyloxy)phenyl]sulfonyl}-1-(2-fluorobenzyl)-5-methoxy-2-methyltryptophan; for treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, ulcerative colitis, or Crohn's disease
07/20/2006US20060160882 Indoline derivatives
07/20/2006US20060160880 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
07/20/2006US20060160879 Indoles useful in the treatment of inflammation
07/20/2006US20060160876 Indole derivatives
07/20/2006US20060160856 Diarylurea derivatives and their use as chloride channel blockers
07/20/2006US20060160847 2,4-Dihalogen-6-(c2-c3alkyl)-phenyl substituted tetramic acid derivatives
07/20/2006US20060160840 Tetrahydroisoquinolines as factor Xa inhibitors
07/20/2006US20060160818 Ocular hypotensive agent
07/20/2006US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
07/20/2006US20060159956 Fluorene-based derivative and organic electroluminescence device employing the same
07/20/2006CA2594391A1 Process for the preparation of substituted indoles
07/20/2006CA2593450A1 Indole derivatives for treating viral infections
07/19/2006EP1680411A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
07/19/2006EP1680401A2 Indolinone derivatives and their use in treating disease-states such as cancer
07/19/2006EP1680397A2 Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
07/19/2006EP1680124A2 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
07/19/2006EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
07/19/2006EP1056452B1 Indole-3-propionic acids, salts and esters thereof used as medicaments
07/19/2006CN1805972A Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
07/19/2006CN1805959A Cycloalkanepyrrolopyridines as DP receptor antagonists
07/19/2006CN1805932A Process and intermediates for the preparation of (1r,2s,5s)-3-azabicyclo[3,1,0]hexane-2-carboxamide, n-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2s)-2-[[[1,1-dimethylethyl]amino]carbonylamino
07/19/2006CN1805931A Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
07/19/2006CN1805930A Hydroxamic acids useful in the treatment of hyper-proliferative disorders
07/19/2006CN1805928A Prodrugs of mitotic kinesin inhibitors
07/19/2006CN1803800A Method for preparing 5-bromine-6-fluoro-8-methyl-1-ethyl-1,3,4,9- tetrahydropyrane[3,4-e] indole-1-ethyl acetate
07/19/2006CN1803784A 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
07/19/2006CN1264848C Pyrrolo[2,1-b] [1,3] benzothiazepines and their use for preparation of medicaments with antipsychotic activity
07/19/2006CN1264841C Preparation of anti-cancer active material in camptothecinum cell and method for restraining cancer cell
07/18/2006USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals
07/18/2006US7078567 Forming c-n bonds; isomerization
07/18/2006US7078535 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
07/18/2006US7078534 Activation the corresponding keto ester; reacting with cysteamine; hydrogenation; crystallization in solvent
07/18/2006US7078521 By reaction of pyrrolobenzothiazepin-9-one with amine to give the corresponding enamine, which is subsequently transformed into the final compound
07/18/2006US7078429 Substituted 3-carbonyl-1H-indol-1-yl acetic acid derivatives for treating conditions resulting from fibrinolytic disorders, such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis; Alzheimer's disease
07/18/2006US7078428 3-(Guanidinylcarbonylmethyl)-substituted; inhibit the cellular sodium-proton antiporter, in particular NHE1; antiarrhythmic agents;cardioprotective for infarction prophylaxis and treatment; preventing ischemia-induced damage
07/18/2006US7078427 Bioavailability; anticancer agents; viricides
07/18/2006US7078425 4-(2-substituted aminocarbonyl-2-substituted aminoethyl)-7-carboxymethoxy- indole, indazole, indoline, benzotriazole or benzoimidazole derivatives, e.g., 4-[2-Benzenesulfonylamino-2-(4-phenyl-butylcarbamoyl)-ethyl]-1H-indazol-7-yloxy}-acetic acid; treating or preventing Type II Diabetes Mellitus
07/18/2006CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
07/18/2006CA2325781C New amino pyrrolin compounds, their preparation process and the pharmaceutical compositions therein
07/18/2006CA2309771C New substitute dimeric derivatives, their preparation process and the pharmaceutical compositions that contain them
07/13/2006WO2006072736A1 N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands
07/13/2006WO2006048893A3 A process for synthesis of large particle size statin compounds
07/13/2006WO2005112945A3 Synthesis of tetracyclines and analogues thereof
07/13/2006WO2005090302A3 Palladium catalyzed indolization of 2-bromo or chloroanilines
07/13/2006WO2004065367A8 Viral polymerase inhibitors
07/13/2006US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting
07/13/2006US20060154343 Simultaneous isomerization at position 2 of monatin having different configurations at positions 2 and 4 in the presence of an aldehyde in a solvent mixture of alcohol and water and crystallization to produce an optical isomer of monatin that has the same configurations at positions 2 and 4 or salt .
07/13/2006CA2594418A1 N-(heteroaryl)-1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands
07/12/2006EP1679303A1 Process for preparing 1-alkoxycarbonyl-3-phenylpropyl derivative
07/12/2006EP1679302A1 Aromatic amino acid labeled with stable isotope, method for incorporating the same into target protein and method for analyzing protein structure using nmr
07/12/2006EP1679301A1 Esters of nonsteroidal anti-inflammatory drugs and methods of their preparation
07/12/2006EP1679072A1 Process for for synthesis of (2S,3aS,7aS)-1-(S)-alanyl-octahydro-1H-indole-2- carboxylic acid derivatives and use in the synthesis of perindopril
07/12/2006EP1678258A1 Cyanine dye labelling reagents
07/12/2006EP1678170A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas
07/12/2006EP1678154A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
07/12/2006EP1678145A2 Benzimidazoles useful as modulators of ion channels
07/12/2006EP1678137A1 Compositions and methods for viral inhibition
07/12/2006EP1678136A1 Process for preparing an azabicyclo[3.1.0]hexane compound
07/12/2006EP1678135A1 Process for the preparation of n-amino substituted heterocyclic compounds
07/12/2006EP1678123A1 Tetrahydro-naphthalene and urea derivatives
07/12/2006EP1678121A2 Tao kinase modulators and methods of use
07/12/2006EP1677794A2 Methods of treating disorder
07/12/2006EP1677783A2 Fibrinogen receptor antagonists and their use
07/12/2006EP1394156B1 Chromene compound
07/12/2006EP1335923B1 Condensed pyridoindole derivatives
07/12/2006CN1802384A Method for synthesis of perindopril and its pharmaceutically acceptable salts
07/12/2006CN1802354A Tetrahydrocarbazole derivatives and their pharmaceutical use
07/12/2006CN1802353A Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
07/12/2006CN1802091A Use of isoindolinone derivatives as insecticides
07/12/2006CN1800183A One-step synthesis process for pemetrexed disodium key intermediate
07/12/2006CN1800145A Substituted 2-dialkylaminoalkylbiphenyl derivatives
07/12/2006CN1263745C Aryl fused azapolycyclic compounds
07/11/2006US7075582 Methods for identifying and using MarR family polypeptide binding compounds
07/11/2006US7074952 Synthesis of taxol enhancers
07/11/2006US7074939 Indole derivatives as anti-inflammatory agents
07/11/2006US7074938 Method for the synthesis of soritin compounds
07/11/2006US7074934 Serine protease inhibitors
07/11/2006US7074837 Acetalization of aldehydes in the presence of acid catalysts, then aminating, cyanating, reducing and cyclization to form heterocyclic amines used as chemical intermediates or bactericides
07/11/2006US7074817 For treating conditions resulting from fibrinolytic disorders such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis
07/11/2006US7074814 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antiarthritic agents ; psoriasis
07/11/2006US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders
07/11/2006US7074805 Especially isoquinolin-5-ylurea derivatives; treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
07/11/2006US7074800 Quinazoline derivatives as angiogenesis inhibitors
07/11/2006US7074796 High affinity for D4 receptors; treatment of psychological disorders such as schizophrenia, generalised anxiety disorder, panic disorder, and obsessive compulsive disorder.
07/11/2006US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor
07/11/2006US7074534 Polymeric charge transport compositions and electronic devices made with such compositions
07/11/2006CA2376876C New isoindoloindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them
07/11/2006CA2344255C Novel derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane, process for preparing them and pharmaceutical compositions containing them
07/11/2006CA2325779C New derivatives of 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbzole and 12,13 (pyranosyl)-furo[3,4-c]indol[2,3-a]carbazole, their preparation process and the pharmaceutical compositions therein
07/11/2006CA2246783C Mcbi analogs of cc-1065 and the duocarmycins
07/11/2006CA2227984C Aza-anthracyclinone derivatives